BEAM
Price
$25.42
Change
+$0.03 (+0.12%)
Updated
Oct 14 closing price
Capitalization
2.57B
26 days until earnings call
Intraday Buy/Sell Signals
FULC
Price
$8.69
Change
-$0.06 (-0.69%)
Updated
Oct 14 closing price
Capitalization
470.06M
28 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

BEAM vs FULC

Header iconBEAM vs FULC Comparison
Open Charts BEAM vs FULCBanner chart's image
Beam Therapeutics
Price$25.42
Change+$0.03 (+0.12%)
Volume$2.03M
Capitalization2.57B
Fulcrum Therapeutics
Price$8.69
Change-$0.06 (-0.69%)
Volume$537.67K
Capitalization470.06M
BEAM vs FULC Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. FULC commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and FULC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (BEAM: $25.39 vs. FULC: $8.69)
Brand notoriety: BEAM and FULC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 104% vs. FULC: 114%
Market capitalization -- BEAM: $2.57B vs. FULC: $470.06M
BEAM [@Biotechnology] is valued at $2.57B. FULC’s [@Biotechnology] market capitalization is $470.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileFULC’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • FULC’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and FULC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while FULC’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • FULC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both BEAM and FULC are a good buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а -1.93% price change this week, while FULC (@Biotechnology) price change was -5.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.86%. For the same industry, the average monthly price growth was +14.21%, and the average quarterly price growth was +268.76%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

FULC is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+0.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.57B) has a higher market cap than FULC($470M). FULC YTD gains are higher at: 84.894 vs. BEAM (2.500). FULC has higher annual earnings (EBITDA): -81.28M vs. BEAM (-414.33M). BEAM has more cash in the bank: 1.15B vs. FULC (214M). FULC has less debt than BEAM: FULC (7.57M) vs BEAM (155M). BEAM has higher revenues than FULC: BEAM (60.3M) vs FULC (0).
BEAMFULCBEAM / FULC
Capitalization2.57B470M547%
EBITDA-414.33M-81.28M510%
Gain YTD2.50084.8943%
P/E RatioN/AN/A-
Revenue60.3M0-
Total Cash1.15B214M537%
Total Debt155M7.57M2,047%
FUNDAMENTALS RATINGS
FULC: Fundamental Ratings
FULC
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
92
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
3

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMFULC
RSI
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 7 days ago
90%
Momentum
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 7 days ago
85%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 7 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 7 days ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 13 days ago
87%
Declines
ODDS (%)
Bearish Trend 19 days ago
85%
Bearish Trend about 1 month ago
85%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
84%
Aroon
ODDS (%)
Bullish Trend 7 days ago
75%
Bullish Trend 7 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSVIX31.860.52
+1.66%
Victory Integrity Small-Cap Value Y
JSVTX16.020.25
+1.59%
Janus Henderson Small-Mid Cap Value T
DFMLX38.630.26
+0.68%
DF Dent Midcap Growth Institutional Plus
CGIIX53.01-0.07
-0.13%
Calamos Growth & Income I
FDTRX219.55-2.93
-1.32%
Franklin DynaTech R6

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+0.12%
CRSP - BEAM
66%
Closely correlated
+1.60%
NTLA - BEAM
63%
Loosely correlated
+0.59%
RXRX - BEAM
61%
Loosely correlated
+6.51%
PRME - BEAM
55%
Loosely correlated
+6.02%
ABSI - BEAM
54%
Loosely correlated
+6.56%
More

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with TRDA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
-0.69%
TRDA - FULC
48%
Loosely correlated
+4.30%
BEAM - FULC
45%
Loosely correlated
+0.12%
ADPT - FULC
45%
Loosely correlated
+0.52%
OCUL - FULC
43%
Loosely correlated
-5.23%
IPSC - FULC
43%
Loosely correlated
+1.78%
More